Efficacy profile
SECONDARY
The secondary endpoint of the trial was to evaluate the beneficial therapeutic effect of the treatments under study by: (i) Rutherford’s classification, (ii) the TcPOTime elapsed to complete wound closure was determined when the wound bed became completely re-epithelialized and filled with new tissue.The percentage of wound closure was calculated using the equation: